IFRS earnings per share vs Sales growth at constant exchange rates

In 2026, IFRS earnings per share worldwide was 0.29 EUR; sales growth at constant exchange rates was 17.8%.

Change the pair

Compare different indicators

The series

Over time

Global, spaced by time in 2026 . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.

IFRS earnings per share

Unit: EUR · 2 observations

Line chart
IFRS earnings per shareIFRS earnings per share. 2 observations from Q1 2026 to Q2 2026, ranging from 0.29 EUR to 1.63 EUR. Latest value 0.29 EUR (Q2 2026). EUR 0 0.5 1 1.5 2 8 Jan 15 Jan 22 Jan 5 Feb 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 1.63 0.29
IFRS earnings per shareIFRS earnings per share. 2 observations from Q1 2026 to Q2 2026, ranging from 0.29 EUR to 1.63 EUR. Latest value 0.29 EUR (Q2 2026). EUR 0 0.5 1 1.5 2 8 Jan 15 Jan 22 Jan 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 1.63 0.29
IFRS earnings per shareIFRS earnings per share. 2 observations from Q1 2026 to Q2 2026, ranging from 0.29 EUR to 1.63 EUR. Latest value 0.29 EUR (Q2 2026). EUR 0 0.5 1 1.5 2 8 Jan 22 Mar Feb 2026 Mar 2026 1.63 0.29
View the underlying data
IFRS earnings per share
Period Type Value
Q1 2026 Actual 1.63 EUR
Q2 2026 Actual 0.29 EUR
Source: Sanofi · CC BY 4.0 · Full series

Sales growth at constant exchange rates

Unit: % · 2 observations

Line chart
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 15 Jan 22 Jan 5 Feb 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 15 Jan 22 Jan 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 22 Mar Feb 2026 Mar 2026 3% 18%
View the underlying data
Sales growth at constant exchange rates
Period Type Value
Q1 2026 Actual 3%
Q2 2026 Actual 17.8%
Source: Roche, Sanofi · CC BY 4.0 · Full series

Shared periods

Side by side

Only one period is published for both series. Comparing anything else would mean comparing different years.

Period IFRS earnings per share Sales growth at constant exchange rates
2026 0.29 EUR 17.8%

Provenance

Where these numbers come from

IFRS earnings per share

Diluted or basic earnings per share reported under International Financial Reporting Standards.

2 observations in Global · source organisations: Sanofi

Sales growth at constant exchange rates

Percentage change in sales calculated at constant exchange rates over the specified period.

2 observations in Global · source organisations: Roche, Sanofi

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related